Clinical Trial Update: Safety and Efficacy Study of LHW090 in Resistant Hypertension Patients [Phase 2]

View source ↗

Summary

Phase 2 trial update reporting safety and efficacy results for LHW090 in patients with resistant hypertension (completed with posted results).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Resistant Hypertension

Drugs mentioned

• LHW090

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Patients, Resistant Hypertension | Phase 2 | Status: COMPLETED | Results posted: 2018-07-05